DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,874,000 | -27.5% | 8,438 | -29.7% | 0.39% | -6.0% |
Q3 2020 | $2,585,000 | +7.8% | 12,003 | -11.5% | 0.42% | +1.5% |
Q2 2020 | $2,399,000 | +19.8% | 13,566 | -6.2% | 0.41% | -3.7% |
Q1 2020 | $2,002,000 | -15.4% | 14,466 | -6.2% | 0.43% | +13.9% |
Q4 2019 | $2,366,000 | +0.7% | 15,416 | -5.2% | 0.38% | -10.1% |
Q3 2019 | $2,349,000 | -7.9% | 16,265 | -8.9% | 0.42% | +11.2% |
Q2 2019 | $2,551,000 | -54.2% | 17,850 | -57.7% | 0.38% | -63.8% |
Q1 2019 | $5,572,000 | +19.5% | 42,200 | -6.6% | 1.04% | +7.9% |
Q4 2018 | $4,662,000 | -6.9% | 45,200 | -2.0% | 0.96% | +10.4% |
Q3 2018 | $5,010,000 | +16.5% | 46,100 | +5.7% | 0.87% | +11.7% |
Q2 2018 | $4,302,000 | +10.1% | 43,600 | +9.3% | 0.78% | +4.9% |
Q1 2018 | $3,906,000 | +31.5% | 39,900 | +24.7% | 0.74% | +35.6% |
Q4 2017 | $2,970,000 | – | 32,000 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |